NBTX
Nanobiotix·NASDAQ
--
--(--)
--
--(--)
NBTX fundamentals
During FY 2025, Nanobiotix (NBTX) reported revenue of 38.25M, a YoY change of 613.89%. Net income was -28.12M, a YoY change of 60.13%. Click to view the full income statement and explore the company's earnings performance.
Income Statement
FY,2018 | H1,2019 | FY,2019 | H1,2020 | FY,2020 | H1,2021 | FY,2021 | H1,2022 | FY,2022 | H1,2023 | FY,2023 | H1,2024 | FY,2024 | H1,2025 | FY,2025 | TTM |
|---|
Start Date | Jan 1, 2018 | Jan 1, 2019 | Jan 1, 2019 | Jan 1, 2020 | Jan 1, 2020 | Jan 1, 2021 | Jan 1, 2021 | Jan 1, 2022 | Jan 1, 2022 | Jan 1, 2023 | Jan 1, 2023 | Jan 1, 2024 | Jan 1, 2024 | Jan 1, 2025 | Jan 1, 2025 | -- |
End Date | Dec 31, 2018 | Jun 30, 2019 | Dec 31, 2019 | Jun 30, 2020 | Dec 31, 2020 | Jun 30, 2021 | Dec 31, 2021 | Jun 30, 2022 | Dec 31, 2022 | Jun 30, 2023 | Dec 31, 2023 | Jun 30, 2024 | Dec 31, 2024 | Jun 30, 2025 | Dec 31, 2025 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 | -- |
Revenue | 3.99M -- | 2.07M -- | 2.85M -28.42% | 1.63M -21.53% | 3.07M +7.69% | 1.56M -3.96% | 3.00M -2.48% | 1.39M -10.97% | 5.11M +70.55% | 3.60M +158.45% | 40.05M +683.90% | 9.95M +176.68% | -7.44M -118.58% | 31.35M +215.12% | 38.25M +613.89% | 38.25M -- |
Sales and Services Revenue | 132.89K -- | 42.08K -- | 76.34K -42.55% | 41.58K -1.20% | 61.15K -19.90% | 11.85K -71.50% | 11.32K -81.49% | -- -- | 0 -100.00% | 0 -- | 33.25M -- | 6.60M -- | -12.02M -136.14% | 29.34M +344.47% | 34.79M +389.51% | 34.79M -- |
Other Revenue | 3.85M -- | 2.03M -- | 2.78M -27.93% | 1.59M -21.95% | 3.01M +8.45% | 1.55M -2.18% | 2.98M -0.88% | 1.39M -10.29% | 5.11M +71.19% | 3.60M +158.45% | 6.80M +33.15% | 3.35M -6.89% | 4.57M -32.76% | 2.01M -39.89% | 3.46M -24.31% | 3.46M -- |
Gross Profit | 3.99M -- | 2.07M -- | 2.85M -28.42% | 1.63M -21.53% | -- -- | 1.56M -3.96% | -- -- | 1.39M -10.97% | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- |
Other Operating Income | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | 56.78K -- | 0 -- | -- -- | 3.11K -- | -- -- | 99.76K +3112.44% | 99.76K -- |
Operating Expenses | 38.43M -- | 25.35M -- | 55.37M +44.08% | 22.29M -12.10% | 47.62M -13.99% | 36.84M +65.32% | 62.50M +31.24% | 28.48M -22.69% | 55.07M -11.89% | 31.36M +10.09% | 69.68M +26.52% | 35.28M +12.52% | 63.35M -9.07% | 30.40M -13.84% | 51.05M -19.42% | 51.05M -- |
Selling, General and Administrative Expenses | 14.50M -- | 10.13M -- | 21.23M +46.46% | 7.59M -25.10% | 17.87M -15.83% | 12.06M +58.84% | 22.00M +23.09% | 10.09M -16.34% | 19.10M -13.15% | 11.86M +17.61% | 24.39M +27.67% | 11.59M -2.32% | 21.25M -12.88% | 13.29M +14.71% | 23.89M +12.46% | 23.89M -- |
Research and Development Expenses | 23.94M -- | 15.22M -- | 34.14M +42.65% | 14.69M -3.44% | 29.76M -12.85% | 18.37M +25.02% | 34.38M +15.55% | 17.39M -5.36% | 34.91M +1.55% | 19.44M +11.83% | 42.47M +21.65% | 23.55M +21.12% | 41.96M -1.20% | 17.10M -27.39% | 27.13M -35.35% | 27.13M -- |
Other Operating Expenses | -- -- | -- -- | -- -- | -- -- | 0 -- | 6.41M -- | 6.13M -- | 1.01M -84.28% | 1.05M -82.80% | 50.23K -95.02% | 2.81M +166.85% | 143.53K +185.73% | 140.77K -94.99% | 8.24K -94.26% | 24.65K -82.49% | 24.65K -- |
Operating Income | -34.44M -- | -23.28M -- | -52.52M -52.47% | -20.66M +11.26% | -44.55M +15.17% | -35.28M -70.78% | -59.51M -33.57% | -27.09M +23.21% | -49.96M +16.04% | -27.70M -2.26% | -29.62M +40.71% | -25.33M +8.56% | -70.79M -138.98% | 951.02K +103.75% | -12.70M +82.07% | -12.70M -- |
Non-Operating Income (Loss) | -318.48K -- | -3.93M -- | -4.64M -1356.97% | -2.47M +37.23% | 3.48M +175.04% | -759.46K +69.20% | 6.32M +81.38% | -496.23K +34.66% | -11.05M -274.98% | -2.98M -499.66% | -14.16M -28.14% | 2.06M +169.25% | 373.67K +102.64% | -7.28M -453.31% | -15.42M -4226.92% | -15.42M -- |
Gain (Loss) on Change in Fair Value | -- -- | -- -- | -- -- | -- -- | -- -- | -- -- | 0 -- | -- -- | 0 -- | -- -- | -4.68M -- | -- -- | 0 +100.00% | -- -- | 0 -- | -- -- |
Gain (Loss) on Foreign Currency Exchange | -- -- | -- -- | -- -- | -- -- | -1.95M -- | -- -- | 7.06M +462.39% | -- -- | 2.25M -68.09% | -182.36K -- | -2.31M -202.72% | 1.68M +1018.60% | 3.09M +233.52% | -4.21M -351.32% | -3.80M -222.84% | -3.80M -- |
Other Non-Operating Income (Loss) | -1.15K -- | -1.14K -- | -- -- | -- -- | 118.63K -- | -- -- | 14.71K -87.60% | -- -- | -7.33M -49942.18% | 883.43K -- | 316.37K +104.31% | 2.92M +230.03% | 2.93M +826.89% | 1.22M -58.18% | -563.33K -119.21% | -563.33K -- |
Net Interest Expense | 317.33K -- | 3.93M -- | 4.64M +1362.23% | 2.47M -37.21% | -5.31M -214.47% | 759.46K -69.20% | 759.44K +114.30% | 496.23K -34.66% | 5.97M +686.18% | 3.68M +640.94% | 7.48M +25.34% | 2.53M -31.19% | 5.65M -24.52% | 4.29M +69.58% | 11.06M +95.84% | 11.06M -- |
Interest Expense | 1.66M -- | 4.75M -- | 5.58M +236.14% | 2.73M -42.56% | -5.31M -195.19% | 3.73M +36.88% | 759.44K +114.30% | 3.08M -17.58% | 6.24M +722.24% | 4.17M +35.42% | 8.83M +41.40% | 4.14M -0.78% | 8.37M -5.21% | 4.99M +20.76% | 12.22M +45.98% | 12.22M -- |
Interest Income | 1.34M -- | 823.48K -- | 939.70K -30.01% | 262.95K -68.07% | 0 -100.00% | 2.98M +1031.42% | 0 -- | 2.58M -13.26% | 273.87K -- | 491.40K -80.96% | 1.35M +391.57% | 1.61M +226.74% | 2.72M +102.14% | 703.85K -56.16% | 1.16M -57.52% | 1.16M -- |
Pretax Income From Continuing Operations | -34.76M -- | -27.21M -- | -57.16M -64.42% | -23.12M +15.01% | -41.07M +28.15% | -36.04M -55.86% | -53.19M -29.52% | -27.59M +23.45% | -61.01M -14.70% | -30.68M -11.21% | -43.78M +28.24% | -23.27M +24.15% | -70.42M -60.83% | -6.33M +72.80% | -28.12M +60.07% | -28.12M -- |
Income Tax Expense | -- -- | -- -- | 3.37K -- | 1.12K -- | 11.01K +226.80% | 2.37K +110.87% | 5.66K -48.59% | 6.28K +165.08% | 10.70K +89.04% | 3.28K -47.85% | 132.74K +1140.83% | 154.24K +4608.13% | 104.55K -21.24% | 7.06K -95.42% | 3.52K -96.63% | 3.52K -- |
Net Income | -34.76M -- | -27.21M -- | -57.16M -64.43% | -23.12M +15.00% | -41.08M +28.13% | -36.04M -55.86% | -53.20M -29.50% | -27.59M +23.44% | -61.02M -14.71% | -30.68M -11.20% | -43.92M +28.03% | -23.43M +23.65% | -70.52M -60.59% | -6.34M +72.96% | -28.12M +60.13% | -28.12M -- |
Net Income Attributable to Owners of the Company | -34.76M -- | -27.21M -- | -57.16M -64.43% | -23.12M +15.00% | -41.08M +28.13% | -36.04M -55.86% | -53.20M -29.50% | -27.59M +23.44% | -61.02M -14.71% | -30.68M -11.20% | -43.92M +28.03% | -23.43M +23.65% | -70.52M -60.59% | -6.34M +72.96% | -28.12M +60.13% | -28.12M -- |
Net Income Attributable to Common Stockholders | -34.76M -- | -27.21M -- | -57.16M -64.43% | -23.12M +15.00% | -41.08M +28.13% | -36.04M -55.86% | -53.20M -29.50% | -27.59M +23.44% | -61.02M -14.71% | -30.68M -11.20% | -43.92M +28.03% | -23.43M +23.65% | -70.52M -60.59% | -6.34M +72.96% | -28.12M +60.13% | -28.12M -- |
Other Comprehensive Income | -152.36K -- | 58.01K -- | 58.38K +138.32% | -5.62K -109.69% | 147.98K +153.48% | -49.76K -785.67% | 99.60K -32.70% | 36.64K +173.63% | 62.05K -37.70% | 12.01K -67.22% | 43.14K -30.47% | -2.14K -117.83% | -27.95K -164.78% | -30.60K -1328.53% | -21.12K +24.41% | -21.12K -- |
Total Comprehensive Income | -34.92M -- | -27.15M -- | -57.10M -63.55% | -23.13M +14.80% | -40.93M +28.32% | -36.09M -56.04% | -53.10M -29.72% | -27.56M +23.65% | -60.96M -14.81% | -30.67M -11.31% | -43.87M +28.03% | -23.43M +23.61% | -70.55M -60.81% | -6.37M +72.83% | -28.14M +60.11% | -28.14M -- |
Total Comprehensive Income Attributable to Owners of the Company | -34.92M -- | -27.15M -- | -57.10M -63.55% | -23.13M +14.80% | -40.93M +28.32% | -36.09M -56.04% | -53.10M -29.72% | -27.56M +23.65% | -60.96M -14.81% | -30.67M -11.31% | -43.87M +28.03% | -23.43M +23.61% | -70.55M -60.81% | -6.37M +72.83% | -28.14M +60.11% | -28.14M -- |
Basic EPS | -1.78 -- | -1.31 -- | -2.64 -48.31% | -1.02 +22.14% | -1.69 +35.98% | -1.04 -1.96% | -1.53 +9.47% | -0.8 +23.08% | -1.75 -14.38% | -0.87 -8.75% | -1.19 +32.00% | -0.49 +43.68% | -1.49 -25.21% | -0.13 +73.47% | -0.59 +60.40% | -0.59 -- |
Basic EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -1.69 -- | -- -- | -1.53 +9.47% | -- -- | -1.75 -14.38% | -0.87 -- | -1.19 +32.00% | -0.49 +43.68% | -1.49 -25.21% | -0.13 +73.47% | -0.59 +60.40% | -0.59 -- |
Diluted EPS | -1.78 -- | -1.31 -- | -2.64 -48.31% | -1.02 +22.14% | -1.69 +35.98% | -1.04 -1.96% | -1.53 +9.47% | -0.8 +23.08% | -1.75 -14.38% | -0.87 -8.75% | -1.19 +32.00% | -0.49 +43.68% | -1.49 -25.21% | -0.13 +73.47% | -0.59 +60.40% | -0.59 -- |
Diluted EPS from Continuing Operations | -- -- | -- -- | -- -- | -- -- | -1.69 -- | -- -- | -1.53 +9.47% | -- -- | -1.75 -14.38% | -0.87 -- | -1.19 +32.00% | -0.49 +43.68% | -1.49 -25.21% | -0.13 +73.47% | -0.59 +60.40% | -0.59 -- |
You can ask Aime
What were the key takeaways from Nanobiotix's earnings call?What is the revenue and EPS growth rate for Nanobiotix year over year?What were the key takeaways from Nanobiotix’s earnings call?What guidance did Nanobiotix's management provide for the next earnings period?What is Nanobiotix's gross profit margin?Did Nanobiotix beat or miss consensus estimates last quarter?What factors drove the changes in Nanobiotix's revenue and profit?What is the market's earnings forecast for Nanobiotix next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
